VERONA PHARMA

verona-pharma-logo

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, such as asthma, allergic rhinitis (hay fever), chronic obstructive pulmonary disease (COPD) and cough. The company creates therapies to address unmet medical requirements in the treatment of respiratory disorders. Verona Pharma was established in 2005 by Clive Page in London, England.

#SimilarOrganizations #People #Financial #Event #Website #More

VERONA PHARMA

Social Links:

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2005-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.veronapharma.com

Total Employee:
51+

Status:
Active

Contact:
+44 20 7863 3300

Email Addresses:
info@veronapharma.com

Total Funding:
1.51 B USD

Technology used in webpage:
Domain Not Resolving IPv6 ReCAPTCHA ReCAPTCHA V2 UNPKG Akamai Hosted


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

arrowhead-pharmaceuticals-logo

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

inovio-pharmaceuticals-logo

Inovio Pharmaceuticals

Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.


Current Advisors List

david-ebsworth_image

David Ebsworth Chairman of the Board @ Verona Pharma
Board_member
2014-01-01

clive-page_image

Clive Page Non-Executive Chairman of the Board Directors @ Verona Pharma
Board_member

Current Employees Featured

clive-page_image

Clive Page
Clive Page Co-Founder @ Verona Pharma
Co-Founder

kathleen-rickard_image

Kathleen Rickard
Kathleen Rickard Chief Medical Officer @ Verona Pharma
Chief Medical Officer
2019-01-01

david-zaccardelli_image

David Zaccardelli
David Zaccardelli President and Chief Executive Officer @ Verona Pharma
President and Chief Executive Officer
2020-02-01

mark-w-hahn_image

Mark W. Hahn
Mark W. Hahn Chief Financial Officer @ Verona Pharma
Chief Financial Officer
2020-02-01

anders-ullman_image

Anders Ullman
Anders Ullman Non Executive Director @ Verona Pharma
Non Executive Director
2013-05-01

desiree-luthman_image

Desiree Luthman
Desiree Luthman Vice President, Regulatory Affairs @ Verona Pharma
Vice President, Regulatory Affairs
2017-01-01

Stock Details


Company's stock symbol is NASDAQ:VRNA

Investors List

oaktree-capital-management_image

Oaktree Capital Management

Oaktree Capital Management investment in Post-IPO Debt - Verona Pharma

ontario-municipal-employees-retirement-system_image

Ontario Municipal Employees Retirement System

Ontario Municipal Employees Retirement System investment in Post-IPO Debt - Verona Pharma

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Verona Pharma

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - Verona Pharma

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Verona Pharma

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Post-IPO Debt - Verona Pharma

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Post-IPO Equity - Verona Pharma

abingworth-management_image

Abingworth

Abingworth investment in Post-IPO Equity - Verona Pharma

david-ebsworth_image

David Ebsworth

David Ebsworth investment in Post-IPO Equity - Verona Pharma

foresite-capital_image

Foresite Capital

Foresite Capital investment in Post-IPO Equity - Verona Pharma

Official Site Inspections

http://www.veronapharma.com Semrush global rank: 1.46 M Semrush visits lastest month: 17.06 K

  • Host name: 192.0.66.210
  • IP address: 192.0.66.210
  • Location: San Francisco United States
  • Latitude: 37.7506
  • Longitude: -122.4121
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94110

Loading ...

More informations about "Verona Pharma"

About Us | Verona Pharma

Verona Pharma is committed to improving the lives of patients with respiratory conditions through innovative prescription medicines. Learn about our vision to meet unmet medical needs, our agile approach, and leadership team.See details»

Verona Pharma - Crunchbase Company Profile

Contact Email info@veronapharma.com Phone Number +44 20 7863 3300 Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, such as asthma, allergic …See details»

Contact Us - Verona Pharma

IR@veronapharma.com. Argot Partners. verona@argotpartners.com +1-212 600 1902. Media Relations. Ten Bridge Communications. tbcverona@tenbridgecommunications.com +1-781 …See details»

Verona Pharma Company Profile | Management and Employees …

Smith@veronapharma.com: Verona Pharma Top Competitors. Company Employees Revenue Top technologies; Synairgen. 17: $4.7 M: Topigen Pharmaceuticals. n/a: $4.5 M: KBP …See details»

Verona Pharma: Contact Details and Business Profile

Verona Pharma is listed on the Nasdaq Global Market in the United States under the ticker symbol VRNA. We are headquartered in London, UK, and have offices in Raleigh and …See details»

Verona Pharma plc - AnnualReports.com

Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs.See details»

Verona Pharma

Nov 21, 2024 Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with …See details»

Verona Pharma Company Overview, Contact Details

May 9, 2024 Verona Pharma plc partners with The Ritedose Corporation. Verona Pharma is partnering with Ritedose, the largest sterile contract development manufacturing organization - …See details»

Mission, Vision & Core Values of Verona Pharma – CBM

Oct 2, 2024 Website: https://www.veronapharma.com; Mission: To discover and develop innovative drugs for the treatment of chronic respiratory diseases; Vision: ... A mission …See details»

Verona Pharma - Craft

Oct 29, 2024 Verona Pharma plc is a United Kingdom-based bio-pharmaceutical company. The Company is engaged in developing drugs for the treatment of chronic respiratory diseases, …See details»

Investor Relations | Verona Pharma

Nov 19, 2024 LONDON and RALEIGH, N.C., Nov. 19, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior …See details»

Verona Pharma Company Profile 2024: Stock Performance

Information on stock, financials, earnings, subsidiaries, investors, and executives for Verona Pharma. Use the PitchBook Platform to explore the full profile.See details»

Verona Pharma Inc. | North Carolina Biotech Center

Verona Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of respiratory diseases such as chronic …See details»

Verona Pharma - Overview, News & Similar companies - ZoomInfo

Oct 13, 2024 Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update LONDON and RALEIGH, N.C., Oct. 21, 2024 (GLOBE NEWSWIRE) -- …See details»

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides …

2 hours ago Approximately $36 million and $42 million net product sales of Ohtuvayre for the fourth quarter and full year 2024, respectivelyMore than 3,500 un...See details»

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In ...

Sep 16, 2024 Ritedose is the largest sterile contract development manufacturing organization (CDMO) in the US specializing in sterile Blow Fill Seal (BFS) technology that ensures sterile, …See details»

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides

2 hours ago Verona Pharma plc: Tel: +1-844-341-9901: Victoria Stewart, Senior Director of Investor Relations and Communications: IR@veronapharma.com: Argot PartnersSee details»

Company Leadership - Verona Pharma

Meet Verona Pharma's leadership team and Board of Directors, with extensive experience in global life sciences and a proven track record in the development and commercialization of …See details»

Verona Pharma Reports Approximately $36 Million in Q4 2024 Net …

2 hours ago Verona Pharma reports $36M in Q4 and $42M in 2024 sales for Ohtuvayre, with over 16,000 prescriptions filled. Quiver AI Summary. Verona Pharma plc has announced its …See details»

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides …

2 hours ago About Verona Pharma. Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory …See details»

linkstock.net © 2022. All rights reserved